Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

<p> A new study lends support to the Centers for Disease Control and Prevention&#39;s (CDC) move in January to recommend early, aggressive treatment with antiviral drugs in patients who present with symptoms of the flu. The new research, conducted by investigators at the University of Michigan, the London School of Hygiene and Tropical Medicine, and the University of Alabama, and published online in <span class="CharOverride-3">The Lancet</span>, found that oseltamivir, which is marketed as Tamiflu, can shorten the duration of symptoms by about a day, and reduces by 44% the development of respiratory infections.<sup><span class="CharOverride-4">1</span></sup></p>

Despite positive new research findings, use of antiviral meds against the flu remains controversial